RT Journal Article
SR Electronic
T1 Testicular microvascular flow is altered in Klinefelter syndrome and predicts circulating testosterone
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.12.21255351
DO 10.1101/2021.04.12.21255351
A1 Francesco Carlomagno
A1 Carlotta Pozza
A1 Marta Tenuta
A1 Riccardo Pofi
A1 Luigi Tarani
A1 Franz Sesti
A1 Marianna Minnetti
A1 Daniele Gianfrilli
A1 Andrea M. Isidori
YR 2021
UL http://medrxiv.org/content/early/2021/04/19/2021.04.12.21255351.abstract
AB Context Experimental studies on Klinefelter syndrome (KS) reported increased intratesticular testosterone (T) levels coexisting with reduced circulating levels. Abnormalities in testicular microcirculation have been claimed; however, no studies investigated in vivo testicular blood flow dynamics in humans with KS.Objective To analyze the testicular microcirculation in KS by contrast-enhanced ultrasonography (CEUS) and correlate vascular parameters with endocrine function.Design and Setting Prospective study. University Settings.Patients 51 testicular scans, 17 testes from 10 T-naïve subjects with KS and 34 testes from age-matched eugonadal men (CNT) who underwent CEUS for incidental nonpalpable testicular lesions.Main Outcomes CEUS kinetic parameters.Results CEUS revealed slower testicular perfusion kinetics in subjects with KS than in age-matched CNT. Specifically, the wash-in time (Tin, p = 0.008), mean transit time (MTT, p = 0.008), time to peak (TTP, p < 0.001), and washout time (Tout 50%, p = 0.008) were all prolonged. Faster testicular blood flow was associated with higher total T levels. Principal component analysis and multiple linear regression analyses confirmed the findings, and supported a role for reduced venous blood flow as independent predictor of total T levels.Conclusions Testicular venous blood flow is altered in KS and independently predicts T peripheral release.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMinistry of Health - NET-2018-12365454.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethic Committee approval, Sapienza University, Policlinico Umberto I, Rome, IT - RIF.CE 5563 prot. Prot n 727/19 of 12/09/2019All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be made available upon reasonable request. https://isidorilab.com/home